Slingshot members are tracking this event:

PDUFA date for Dupixent (dupilumab) in Nasal polyps under priority review June 26, 2019

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
SNY Community voting in process
REGN Community voting in process
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Dupixent, Dupilumab, Nasal Polyps